4//SEC Filing
Janku Filip 4
Accession 0000950170-24-106387
CIK 0001826457other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:30 PM ET
Size
5.6 KB
Accession
0000950170-24-106387
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-13+30,000→ 30,000 totalExercise: $7.56Exp: 2032-10-04→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]On October 3, 2022, the Reporting Person was granted an option to purchase 30,000 shares of Common Stock, subject to the satisfaction of certain performance criteria. On September 13, 2024, the performance criteria underlying such shares were met.
- [F2]The shares underlying this option shall vest in full on March 13, 2026, subject to the Reporting Person's continued service on such date.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001862930
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:30 PM ET
- Size
- 5.6 KB